These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 3734034)

  • 1. Pituitary-adrenal response to the antiglucocorticoid action of RU 486 in Cushing's syndrome.
    Bertagna X; Bertagna C; Laudat MH; Husson JM; Girard F; Luton JP
    J Clin Endocrinol Metab; 1986 Sep; 63(3):639-43. PubMed ID: 3734034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The new steroid analog RU 486 inhibits glucocorticoid action in man.
    Bertagna X; Bertagna C; Luton JP; Husson JM; Girard F
    J Clin Endocrinol Metab; 1984 Jul; 59(1):25-8. PubMed ID: 6327758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.
    Laue L; Chrousos GP; Loriaux DL; Barnes K; Munson P; Nieman L; Schaison G
    J Clin Endocrinol Metab; 1988 Feb; 66(2):290-3. PubMed ID: 2828406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation.
    Bertagna X; Escourolle H; Pinquier JL; Coste J; Raux-Demay MC; Perles P; Silvestre L; Luton JP; Strauch G
    J Clin Endocrinol Metab; 1994 Feb; 78(2):375-80. PubMed ID: 8106625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU 486.
    Nieman LK; Chrousos GP; Kellner C; Spitz IM; Nisula BC; Cutler GB; Merriam GR; Bardin CW; Loriaux DL
    J Clin Endocrinol Metab; 1985 Sep; 61(3):536-40. PubMed ID: 2991327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mifepristone: treatment of Cushing's syndrome.
    Sartor O; Cutler GB
    Clin Obstet Gynecol; 1996 Jun; 39(2):506-10. PubMed ID: 8734015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antiglucocorticoid and antiprogestin steroid RU 486: its glucocorticoid agonist effect is inadequate to prevent adrenal insufficiency in primates.
    Laue L; Gallucci W; Loriaux DL; Udelsman R; Chrousos GP
    J Clin Endocrinol Metab; 1988 Sep; 67(3):602-6. PubMed ID: 2842364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antiglucocorticoid action of RU 486].
    Bertagna X
    Ann Endocrinol (Paris); 1989; 50(3):208-17. PubMed ID: 2554782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of adrenal autonomy in Cushing's syndrome: a comparison between in vivo and in vitro responsiveness of the adrenal gland.
    Lamberts SW; Zuiderwijk J; Uitterlinden P; Blijd JJ; Bruining HA; de Jong FH
    J Clin Endocrinol Metab; 1990 Jan; 70(1):192-9. PubMed ID: 2152930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RU 486: a steroid with antiglucocorticosteroid activity that only disinhibits the human pituitary-adrenal system at a specific time of day.
    Gaillard RC; Riondel A; Muller AF; Herrmann W; Baulieu EE
    Proc Natl Acad Sci U S A; 1984 Jun; 81(12):3879-82. PubMed ID: 6328529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient inhibition of RU 486 antiglucocorticoid action by dexamethasone.
    Raux-Demay MC; Pierret T; Bouvier d'Yvoire M; Bertagna X; Girard F
    J Clin Endocrinol Metab; 1990 Jan; 70(1):230-3. PubMed ID: 2152931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mifepristone (RU 486) in Cushing's syndrome.
    Johanssen S; Allolio B
    Eur J Endocrinol; 2007 Nov; 157(5):561-9. PubMed ID: 17984235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the antiserotonin drug, cyproheptadine, on plasma beta-endorphin and beta-lipotropin in patients with Itsenko-Cushing's disease.
    Slavnov VN; Valueva GV; Luchitsky EV
    Exp Clin Endocrinol; 1985 Jun; 85(3):341-50. PubMed ID: 2995088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
    Katznelson L; Bogan JS; Trob JR; Schoenfeld DA; Hedley-Whyte ET; Hsu DW; Zervas NT; Swearingen B; Sleeper M; Klibanski A
    J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of ketoconazole in the treatment of Cushing's syndrome.
    Loli P; Berselli ME; Tagliaferri M
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1365-71. PubMed ID: 3023421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis.
    Trainer PJ; Faria M; Newell-Price J; Browne P; Kopelman P; Coy DH; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 1995 Feb; 80(2):412-7. PubMed ID: 7852498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RU 486 administration in a child with Cushing's syndrome.
    Beaufrère B; de Parscau L; Chatelain P; Morel Y; Aguercif M; François R
    Lancet; 1987 Jul; 2(8552):217. PubMed ID: 2885668
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Addison's disease and Cushing's syndrome: basal concentrations.
    Peterson ME; Orth DN; Halmi NS; Zielinski AC; Davis DR; Chavez FT; Drucker WD
    Endocrinology; 1986 Aug; 119(2):720-30. PubMed ID: 3015556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.